A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster α1B-adrenoceptors

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 363, Issue 1, 2001, Pages 34-39

  Hein, P ^a   Goepel, Mark ^b   Cotecchia, Susanna ^c   Michel, M C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Doxazosin; Inverse agonism; Tamsulosin; Terazosin; 1B Adrenoceptors

Indexed keywords

2 [2 (4 HYDROXYPHENYL)ETHYLAMINOMETHYL]TETRALONE; 8 [3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]PROPYLCARBAMOYL] 3 METHYLFLAVONE; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1B ADRENERGIC RECEPTOR; DOXAZOSIN; INOSITOL PHOSPHATE; PHENYLEPHRINE; PRAZOSIN; QUINAZOLINE DERIVATIVE; TAMSULOSIN; TERAZOSIN; TRITIUM;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; FIBROBLAST CULTURE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CELL LINE; CHROMONES; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXAZOSIN; FIBROBLASTS; INOSITOL PHOSPHATES; PHENETHYLAMINES; PRAZOSIN; QUINAZOLINES; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; SULFONAMIDES; TETRALONES; TRITIUM;

EID: 0035167487     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002100000329     Document Type: Article

References (28)

1. 1B-adrenergic receptor enhances mitogenesis and tumorigenicity
2. Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinary tract symptoms suggestive of bladder outlet obstruction (symptomatic benign prostatic hyperplasia)
3. 1-adrenoceptor selectivity?
4. 1A-adrenoceptor antagonist A meta-analysis of two randomized, placebo-controlled multicentre studies in patients with benign prostatic obstruction (symptomatic BPH)
5. 50) of an enzymatic reaction
6. 1-adrenoceptor
7. A doubleblind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing
8. 1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction
9. 1 MF-2 cells: Comparison of receptor density and response
10. 1d-adrenoceptors
11. 1adrenoceptors in humans
12. 1B-adrenoceptors
13. 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: Studies on tamsulosin in a fixed dose and terazosin in increasing doses
14. 1B-adrenoceptor by ligands that act as inverse agonists
15. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia
16. Coadministration of tamsulosin and three antihypertensive agents in patients with benign prostatic hyperplasia: Pharmacodynamic effect
17. 1-adrenoceptor subtypes and in human prostate
18. Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: Does comorbidity alter tolerability?
19. Inverse agonism: Pharmacological curiosity or potential therapeutic strategy?
20. Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation
21. A second phase III multicenter placebo controlled study of 2 dosages of modified release tamsulosin in patients with symptoms of benign prostatic hyperplasia
22. Functional evidence of inverse agonism in vascular smooth muscle
23. 1b-adrenergic receptor subtypes
24. 1-adrenoceptor antagonism by tamsulosin and terazosin
25. Radioreceptor assay analysis of tamsulosin and terazosin pharmacokinetics
26. 1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways
27. α-Adrenoceptor blocking agents in the treatment of hypertension
28. 1D-adrenoceptor protein detectable in rat tissues?